Fermentalg (FALG) Q1 2026 TU earnings summary

Executive summary

• Achieved record Q1 2026 turnover of €3.7 million, surpassing previous Q1 highs.

• Sales diversification strategy succeeded, with strong growth in high-margin segments.

• Commercial launches of QRIGINST EPA/DHA range and Galdieria Blue expected to impact H2 2026.

• Reaffirmed ambition to reach €20 million turnover in 2026.

Financial highlights

• Q1 2026 revenue reached €3.7 million, up from €3.6 million in Q1 2025.

• Sales excluding aquaculture grew 42% year-over-year, from €2.6 million to €3.7 million.

• Temporary shift away from low-margin aquaculture segment.

Outlook and guidance

• Anticipates sharp acceleration in growth in H2 2026 due to new product launches.

• Maintains target of €20 million in annual revenue for 2026.

• Potential return to aquaculture segment by year-end as economic competitiveness improves.